Raymond Cohen has over 30 years of experience in leading medical device companies. Previously he was CEO of a privately-held venture capital backed Vessix Vascular which was acquired by Boston Scientific in November 2012. Cohen spent nearly a decade as Chairman & CEO of Nasdaq-listed Cardiac Science Inc. ranked as the 4th fastest growing company in U.S. in 2004. Currently, Mr. Cohen is Chairman of a number of private and publicly traded life science companies including UK-based Lombard Medical (LSE: LMT.L endovascular AAA stent graft), Munich-based JenaValve Technologies (TAVI) and Seattle-based BioLife Solutions (Nasdaq: BLFS – preservation media for human cells). Cohen also serves as a director of Spectrum Pharmaceuticals (Nasdaq: SPPI – Oncology drugs).